JPRN-UMIN000045414招募中未知
A phase II trial of the efficacy and safety of boring biopsy with rapid on-site evaluation for histological diagnosis of gastric mesenchymal tumor - A phase II trial of the efficacy and safety of boring biopsy with rapid on-site evaluation for histological diagnosis of gastric mesenchymal tumor
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-The lesion is difficult to recognize by white light endoscopy. -The Lesion is present in the cardia.
研究者
相似试验
已完成
不适用
Phase one/ two clinical trial of boron neutro capture therapy for head and neck malignanciesHead and Neck cancersJPRN-UMIN000027543Kawasaki Medical School15
招募中
不适用
A Phase II trial to evaluate the efficacy of Bortezomib, Cytarabine, and Dexamethasone in patients with relapsed or refractory mantle cell lymphomaKCT0004010Seoul National University Hospital32
招募中
不适用
Phase1/2study evaluating safety and efficacy of bortezomib-lenalidomid-dexamethasone induction therapy followed by lenalidomide-dexamethasone consolidation and lenalidomide maintenance for newly diagnosed patients with multiple myeloma eligible for stem cell transplantation.Multiple myelomaJPRN-UMIN000016874Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital30
进行中（未招募）
不适用
A pilot phase II study to assess the efficacy of Brentuximab Vedotin administered sequentally with ABVD chemotherapy in patients with untreated Hodgkin LymphomaEUCTR2012-002012-46-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA
进行中（未招募）
1 期
clinical study to evaluate the efficacy and safety of a new drug (Bardoxolone methyl) in the treatment of subjects with Alport syndromeMedDRA version: 20.0Level: PTClassification code 10001843Term: Alport's syndromeSystem Organ Class: 10010331 - Congenital, familial and genetic disordersAlport SyndromeEUCTR2016-004395-22-FRReata Pharmaceuticals, Inc.187